170329 1 Notice Pursuant to Listing rule 7.12.1

Market release
29 March 2017

NOTICE PURSUANT TO LISTING RULE 7.12.1

For the purposes of Rule 7.12.1 of the NZX Main Board Listing Rules, AFT Pharmaceuticals
Limited (NZX: AFT; ASX:AFP) advises that the following Securities have been issued:

a) Class of Security

Unlisted redeemable preference shares in
AFT Pharmaceuticals Limited (“Redeemable
Preference Shares”)
ISIN: N/A
b) Number issued: 3,330,000 Redeemable Preference Shares
c) Issue price: $2.74 per Redeemable Preference Share
d) Payment in cash: Yes
e) Amount paid up: Fully paid
f) Principal terms of the Securities See AFT Pharmaceuticals Limited’s market
announcement of 17 March 2017 for a
summary of the principal terms of the
Redeemable Preference Shares
g) Percentage of the total of Class of
Securities issued:
100%
h) Reason for issue: See AFT Pharmaceuticals Limited’s market
announcement of 17 March 2017 for the
reasons for the issue of the Redeemable
Preference Shares
i) Specific authority for issue: Board resolution

j) Terms or details of issue: See AFT Pharmaceuticals Limited’s market
announcement of 17 March 2017 for a
summary of the details of the issue of
Redeemable Preference Shares
k) Total number of Securities of the Class
in existence after issue:
3,330,000 Redeemable Preference Shares
l) Treasury stock N/A
m) Date of issue: 24 March 2017

[End of release]

For more information:
Malcolm Tubby
CFO, AFT Pharmaceuticals Ltd
Phone: +64 9 488 0232